66 related articles for article (PubMed ID: 15258356)
1. Endothelium and hemorheology.
Turchetti V; Boschi L; Donati G; Borgogni G; Coppola D; Dragoni S; Bellini MA; Sicuro S; Mastronuzzi VM; Forconi S
Clin Hemorheol Microcirc; 2004; 30(3-4):289-95. PubMed ID: 15258356
[TBL] [Abstract][Full Text] [Related]
2. Impact of hemorheological and endothelial factors on microcirculation.
Turchetti V; Boschi L; Donati G; Trabalzini L; Forconi S
Adv Exp Med Biol; 2006; 578():107-12. PubMed ID: 16927678
[TBL] [Abstract][Full Text] [Related]
3. A possible involvement of crosstalk between advanced glycation end products (AGEs) and asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor in accelerated atherosclerosis in diabetes.
Yamagishi S; Ueda S; Okuda S
Med Hypotheses; 2007; 69(4):922-4. PubMed ID: 17368960
[TBL] [Abstract][Full Text] [Related]
4. Relationship between protective effects of rosiglitazone on endothelium and endogenous nitric oxide synthase inhibitor in streptozotocin-induced diabetic rats and cultured endothelial cells.
Wang S; Jiang JL; Hu CP; Zhang XJ; Yang DL; Li YJ
Diabetes Metab Res Rev; 2007 Feb; 23(2):157-64. PubMed ID: 16770837
[TBL] [Abstract][Full Text] [Related]
5. Asymmetric dimethylarginine (ADMA) and soluble vascular cell adhesion molecule 1(sVCAM-1) as circulating markers for endothelial dysfunction in patients with pheochromocytoma.
Vasilev V; Matrozova J; Elenkova A; Vandeva S; Kirilov G; Zacharieva S
Exp Clin Endocrinol Diabetes; 2013 Oct; 121(9):551-5. PubMed ID: 24002898
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of endogenous nitric oxide synthesis in congenital urea cycle enzyme defects.
Nagasaka H; Tsukahara H; Yorifuji T; Miida T; Murayama K; Tsuruoka T; Takatani T; Kanazawa M; Kobayashi K; Okano Y; Takayanagi M
Metabolism; 2009 Mar; 58(3):278-82. PubMed ID: 19217439
[TBL] [Abstract][Full Text] [Related]
7. Arterial elasticity is associated with endothelial vasodilatory function and asymmetric dimethylarginine level in healthy subjects.
Kals J; Kampus P; Kals M; Teesalu R; Zilmer K; Pulges A; Zilmer M
Scand J Clin Lab Invest; 2007; 67(5):536-44. PubMed ID: 17763190
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
[TBL] [Abstract][Full Text] [Related]
9. High serum TNF-alpha level in Type 2 diabetic patients with microangiopathy is associated with eNOS down-regulation and apoptosis in endothelial cells.
Makino N; Maeda T; Sugano M; Satoh S; Watanabe R; Abe N
J Diabetes Complications; 2005; 19(6):347-55. PubMed ID: 16260352
[TBL] [Abstract][Full Text] [Related]
10. Estradiol counteracts oxidized LDL-induced asymmetric dimethylarginine production by cultured human endothelial cells.
Monsalve E; Oviedo PJ; García-Pérez MA; Tarín JJ; Cano A; Hermenegildo C
Cardiovasc Res; 2007 Jan; 73(1):66-72. PubMed ID: 17097077
[TBL] [Abstract][Full Text] [Related]
11. Regulation of coronary blood flow during exercise.
Duncker DJ; Bache RJ
Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
[TBL] [Abstract][Full Text] [Related]
12. Prevention by NCX 4016, a nitric oxide-donating aspirin, but not by aspirin, of the acute endothelial dysfunction induced by exercise in patients with intermittent claudication.
Gresele P; Migliacci R; Procacci A; De Monte P; Bonizzoni E
Thromb Haemost; 2007 Mar; 97(3):444-50. PubMed ID: 17334512
[TBL] [Abstract][Full Text] [Related]
13. [Hemorheology and vascular endothelial cells].
Stoltz JF; Boisseau M; Muller S; Wang X; Legrand S; Labrador MV
J Mal Vasc; 1999 May; 24(2):99-109. PubMed ID: 10399642
[TBL] [Abstract][Full Text] [Related]
14. Advanced glycation end-product peptides are associated with impaired renal function, but not with biochemical markers of endothelial dysfunction and inflammation, in non-diabetic individuals.
Stam F; Schalkwijk CG; van Guldener C; ter Wee PM; Stehouwer CD
Nephrol Dial Transplant; 2006 Mar; 21(3):677-82. PubMed ID: 16330467
[TBL] [Abstract][Full Text] [Related]
15. Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure.
Amabile N; Guérin AP; Leroyer A; Mallat Z; Nguyen C; Boddaert J; London GM; Tedgui A; Boulanger CM
J Am Soc Nephrol; 2005 Nov; 16(11):3381-8. PubMed ID: 16192427
[TBL] [Abstract][Full Text] [Related]
16. Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes.
Stirban A; Negrean M; Stratmann B; Gawlowski T; Horstmann T; Götting C; Kleesiek K; Mueller-Roesel M; Koschinsky T; Uribarri J; Vlassara H; Tschoepe D
Diabetes Care; 2006 Sep; 29(9):2064-71. PubMed ID: 16936154
[TBL] [Abstract][Full Text] [Related]
17. [Endothelial function in high risk cardiovascular patients].
Káli A; Jánosi A
Orv Hetil; 2006 Jan; 147(3):99-106. PubMed ID: 16515028
[TBL] [Abstract][Full Text] [Related]
18. Asymmetric dimethylarginine (ADMA): the silent transition from an 'uraemic toxin' to a global cardiovascular risk molecule.
Fliser D
Eur J Clin Invest; 2005 Feb; 35(2):71-9. PubMed ID: 15667575
[TBL] [Abstract][Full Text] [Related]
19. [Relationship between hemorheology and pro- and anti-coagulation factors in inflammatory and degenerative vascular diseases].
Cortinovis A; Crippa A; Crippa M
Minerva Med; 1994 Sep; 85(9):439-49. PubMed ID: 7936365
[TBL] [Abstract][Full Text] [Related]
20. Hemorheology and vascular control mechanisms.
Baskurt OK; Yalcin O; Meiselman HJ
Clin Hemorheol Microcirc; 2004; 30(3-4):169-78. PubMed ID: 15258340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
